PALIClinical Trials•globenewswire•August 25, 2025 at 01:00 PM

Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108

Sentiment:Negative (30)

– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan

Read the full article from the original source for complete details and context.

Article published on August 25, 2025 by globenewswire